Annual Total Liabilities
$42.55 M
+$30.37 M+249.35%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual total liabilities is $42.55 million, with the most recent change of +$30.37 million (+249.35%) on September 30, 2024.
- During the last 3 years, CTXR annual total liabilities has risen by +$32.90 million (+341.10%).
- CTXR annual total liabilities is now at all-time high.
Performance
CTXR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$42.55 M
+$31.74 M+293.75%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly total liabilities is $42.55 million, with the most recent change of +$31.74 million (+293.75%) on September 30, 2024.
- Over the past year, CTXR quarterly total liabilities has increased by +$31.74 million (+293.75%).
- CTXR quarterly total liabilities is now at all-time high.
Performance
CTXR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CTXR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +249.3% | +293.8% |
| 3 y3 years | +341.1% | +293.8% |
| 5 y5 years | +343.5% | +293.8% |
CTXR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +341.1% | at high | +343.7% |
| 5 y | 5-year | at high | +343.5% | at high | +950.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Citius Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $42.55 M(+249.4%) | $42.55 M(+293.8%) |
| Jun 2024 | - | $10.81 M(+0.6%) |
| Mar 2024 | - | $10.74 M(-10.9%) |
| Dec 2023 | - | $12.07 M(-0.9%) |
| Sep 2023 | $12.18 M(+15.2%) | $12.18 M(+0.6%) |
| Jun 2023 | - | $12.10 M(-2.7%) |
| Mar 2023 | - | $12.43 M(+16.5%) |
| Dec 2022 | - | $10.67 M(+0.9%) |
| Sep 2022 | - | $10.57 M(+5.9%) |
| Sep 2022 | $10.57 M(+9.6%) | - |
| Jun 2022 | - | $9.98 M(+4.1%) |
| Mar 2022 | - | $9.59 M(-26.0%) |
| Dec 2021 | - | $12.96 M(+34.3%) |
| Sep 2021 | $9.65 M(-4.5%) | $9.65 M(+3.6%) |
| Jun 2021 | - | $9.31 M(+4.6%) |
| Mar 2021 | - | $8.90 M(-6.4%) |
| Dec 2020 | - | $9.51 M(-5.9%) |
| Sep 2020 | $10.10 M(+5.3%) | $10.10 M(+4.6%) |
| Jun 2020 | - | $9.66 M(+138.5%) |
| Mar 2020 | - | $4.05 M(-12.1%) |
| Dec 2019 | - | $4.61 M(-52.0%) |
| Sep 2019 | $9.59 M(+201.2%) | $9.59 M(+137.6%) |
| Jun 2019 | - | $4.04 M(+20.1%) |
| Mar 2019 | - | $3.36 M(-13.8%) |
| Dec 2018 | - | $3.90 M(+22.5%) |
| Sep 2018 | $3.18 M | $3.18 M(+45.4%) |
| Jun 2018 | - | $2.19 M(-14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $2.56 M(-2.1%) |
| Dec 2017 | - | $2.62 M(+6.0%) |
| Sep 2017 | $2.47 M(-52.4%) | $2.47 M(-75.2%) |
| Jun 2017 | - | $9.97 M(+35.8%) |
| Mar 2017 | - | $7.34 M(+16.2%) |
| Dec 2016 | - | $6.32 M(+21.9%) |
| Sep 2016 | $5.18 M(+276.5%) | $5.18 M(+6.8%) |
| Jun 2016 | - | $4.85 M(+11.5%) |
| Mar 2016 | - | $4.35 M(+124.7%) |
| Dec 2015 | - | $1.94 M(+40.7%) |
| Sep 2015 | $1.38 M(-40.1%) | $1.38 M(-35.7%) |
| Jun 2015 | - | $2.14 M(+27.3%) |
| Mar 2015 | - | $1.68 M(+2.3%) |
| Dec 2014 | - | $1.65 M(-28.4%) |
| Sep 2014 | $2.30 M(>+9900.0%) | $2.30 M(+7222.9%) |
| Jun 2014 | - | $31.40 K(+25.1%) |
| Mar 2014 | - | $25.10 K(+19.5%) |
| Dec 2013 | - | $21.00 K(+42.9%) |
| Sep 2013 | $14.70 K(-68.0%) | $14.70 K(-76.3%) |
| Jun 2013 | - | $62.00 K(+7.6%) |
| Mar 2013 | - | $57.60 K(+21.5%) |
| Dec 2012 | - | $47.40 K(+3.0%) |
| Sep 2012 | $46.00 K(+90.9%) | $46.00 K(+13.3%) |
| Jun 2012 | - | $40.60 K(+20.8%) |
| Mar 2012 | - | $33.60 K(+26.3%) |
| Dec 2011 | - | $26.60 K(+10.4%) |
| Sep 2011 | $24.10 K | $24.10 K(+14.2%) |
| Jun 2011 | - | $21.10 K |
FAQ
- What is Citius Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual total liabilities year-on-year change?
- What is Citius Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly total liabilities year-on-year change?
What is Citius Pharmaceuticals annual total liabilities?
The current annual total liabilities of CTXR is $42.55 M
What is the all time high annual total liabilities for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual total liabilities is $42.55 M
What is Citius Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CTXR annual total liabilities has changed by +$30.37 M (+249.35%)
What is Citius Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CTXR is $42.55 M
What is the all time high quarterly total liabilities for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly total liabilities is $42.55 M
What is Citius Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CTXR quarterly total liabilities has changed by +$31.74 M (+293.75%)